Putnam Investments’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $14.2M | Sell |
|
|||||
|
2021
Q2 | $28.4M | Sell |
|
|||||
|
2021
Q1 | $33.9M | Sell |
|
|||||
|
2020
Q4 | $36.4M | Sell |
|
|||||
|
2020
Q3 | $32.1M | Buy |
|
|||||
|
2020
Q2 | $23.3M | Buy |
|
|||||
|
2020
Q1 | $14.6M | Buy |
|
|||||
|
2019
Q4 | $4.91M | Buy |
|
|||||
|
2019
Q3 | $2.77M | Buy |
|
|||||
|
2019
Q2 | $2.87M | Hold |
|
|||||
|
2019
Q1 | $3.26M | Buy |
|
|||||
|
2018
Q4 | $3.04M | Buy |
|
|||||
|
2018
Q3 | $3.72M | Buy |
|
|||||
|
2018
Q2 | $1.26M | Sell |
|
|||||
|
2018
Q1 | $1.12M | Buy |
|
|||||
|
2017
Q4 | $1.21M | Sell |
|
|||||
|
2017
Q3 | $1.59M | Buy |
|
|||||
|
2017
Q2 | $912K | Sell |
|
|||||
|
2017
Q1 | $3.62M | Sell |
|
|||||
|
2016
Q4 | $3.53M | Sell |
|
|||||
|
2016
Q3 | $5.03M | Buy |
|
|||||
|
2016
Q2 | $4.25M | Hold |
|
|||||
|
2016
Q1 | $3.3M | Hold |
|
|||||
|
2015
Q4 | $6.09M | Sell |
|
|||||
|
2015
Q3 | $3.12M | Hold |
|
|||||
|
2015
Q2 | $3.97M | Buy |
|